Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire
300 Leser
Artikel bewerten:
(1)

Nasdaq Helsinki Ltd: Coronaria announces an obligation to launch a mandatory public tender offer for all shares in Silmäasema Oyj

Coronaria Oy

Stock Exchange Release

August 16, 2019 at 9:45 a.m. EEST


NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH
AFRICA OR HONG KONG, OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER
WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER IN-FORMATION, SEE SECTION
"IMPORTANT INFORMATION" BELOW. 

Coronaria announces an obligation to launch a mandatory public tender offer for
all shares in Silmäasema Oyj 

Coronaria Oy ("Coronaria") has, through share purchases made on 15 and 16
August 2019, acquired a total of 1,420,031 shares in Silmäasema Oyj
("Silmäasema" or "Company"). The highest price paid for the shares has been EUR
6.00 per share, which is also the highest price paid by Coronaria for the
shares in Silmäasema. 

As a result of the share purchases, Coronaria's shareholding in Silmäasema
increases to a total of 4,615,443 shares, corresponding to 32.4 per cent of all
shares and voting rights in the Company, respectively. Consequently,
Coronaria's holding in Silmäasema exceeds 30 per cent of the shares and voting
rights carried by Silmäasema's shares and Coronaria is thereby obligated to
launch a mandatory public tender offer for all shares and securities entitling
to shares in Silmäasema ("Tender Offer") in accordance with the Securities
Markets Act. 

Prior to the share purchases, Coronaria held 3,195,412 shares in Silmäasema,
representing 22.43 per cent of all outstanding shares in Silmäasema. Coronaria
is Silmäasema's largest shareholder. 

In the Tender Offer, Coronaria will offer cash consideration of EUR 6.00 per
share in Silmäasema. The cash consideration represents a premium of
approximately 7.5 per cent compared to the closing price of the Silmäasema
share on Nasdaq Helsinki on 15 August 2019, the last trading day before the
announcement of the Tender Offer, and a premium of approximately 9.4 per cent
compared to the volume-weighted average price of the Silmäasema shares on
Nasdaq Helsinki during the three-month time period preceding the date of the
announcement of the Tender Offer. 

Coronaria aims to commence the offer period of the Tender Offer on 16 September
2019 at the latest. The Tender Offer will be published immediately after the
Finnish Financial Supervisory Authority has approved the offer document, which
includes the detailed terms and conditions of the Tender Offer. The offer
period will be three weeks. According to Coronaria, the completion of the
Tender Offer does not require approval from the competition authorities. 

Coronaria reserves the right to acquire shares in the Company before the
commencement of the offer period, during the offer period and/or after the
offer period of the Tender Offer through public trading on Nasdaq Helsinki or
otherwise. 

"Through the share purchases carried out, Coronaria was presented with an
opportunity to increase its investment in an industry it is well acquainted
with. This resulted in an obligation for Coronaria to make a mandatory public
tender offer for all the shareholders of Silmäasema," says Teppo Lindén, CEO of
Coronaria Oy. 

Carnegie Investment Bank AB, Finland Branch, acts as financial advisor and
Roschier, Attorneys Ltd as legal advisor to Coronaria in the Tender Offer. 

FOR MORE INFORMATION, PLEASE CONTACT:

Teppo Lindén

CEO

Coronaria Oy

Tel. +358 400 684 119

teppo.linden@coronaria.fi





IMPORTANT INFORMATION

THIS RELEASE MAY NOT BE RELEASED OR OTHERWISE DISTRIBUTED, IN WHOLE OR IN PART,
DIRECTLY OR INDI-RECTLY, IN OR INTO, THE UNITED STATES, CANADA, JAPAN,
AUSTRALIA, SOUTH AFRICA OR HONG KONG OR IN ANY OTHER JURISDICTION IN WHICH THE
TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. 

THIS RELEASE IS NOT A TENDER OFFER DOCUMENT AND AS SUCH DOES NOT CONSTITUTE AN
OFFER OR INVI-TATION TO MAKE A SALES OFFER. IN PARTICULAR, THIS RELEASE IS NOT
AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES
DESCRIBED HEREIN, AND IS NOT AN EXTENSION OF THE TENDER OFFER, IN OR INTO, THE
UNITED STATES CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR HONG KONG. INVESTORS
SHALL ACCEPT THE TENDER OFFER FOR THE SHARES ONLY ON THE BASIS OF THE
INFORMATION PROVIDED IN A TENDER OFFER DOCUMENT. OFFERS WILL NOT BE MADE
DIRECTLY OR INDIRECTLY IN ANY JURISDICTION WHERE EITHER AN OFFER OR
PARTICIPATION THEREIN IS PROHIBITED BY APPLICABLE LAW OR WHERE ANY TENDER OFFER
DOCUMENT OR REGISTRATION OR OTHER REQUIREMENTS WOULD APPLY IN ADDITION TO THOSE
UNDERTAKEN IN FINLAND.
© 2019 GlobeNewswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.